\-\ Texto\\:\\ \ \(0\)\
\-\ head\\ circumference\\:\\ 41cm\\.\\ \\ hypotelorism\\.\\ \\ normal\\ newborn\\ metabolic\\ screening\\ labs\\.\ \(0\)\
\-\ treatment\\ of\\ craniosynostosis\\ is\\ primarily\\ surgical\\.\\ \\ these\\ infants\\ are\\ usually\\ operated\\ on\\ early\\ in\\ their\\ life\\.\\ patients\\ with\\ metopic\\ craniosynostosis\\ are\\ treated\\ prior\\ to\\ sixth\\ months\\ of\\ age\\.\ \(0\)\
\-\ factors\\ that\\ may\\ necessitate\\ earlier\\ treatment\\ are\\ increasing\\ intracranial\\ pressure\\ and\\ corneal\\ exposure\\ secondary\\ to\\ exorbitism\\.\ \(0\)\
\-\ the\\ procedure\\ to\\ correct\\ symmetric\\ craniosynostosis\\ \\(as\\ in\\ this\\ case\\)\\ involves\\ fracturing\\ the\\ bone\\ parallel\\ to\\ the\\ affected\\ suture\\.\\ \\ a\\ synthetic\\ material\\ graft\\ is\\ placed\\ between\\ the\\ bone\\ and\\ the\\ new\\ \\‚\\Ä\\úsuture\\‚\\Ä\\ù\\ that\\ helps\\ delay\\ fusion\\.\ \(0\)\
\-\ trigonocephaly\ \(1\)\
\-\ hypotelorism\\ \\(eyes\\ too\\ close\\ together\\)\ \(0\)\
\-\ mild\\ macrocephaly\\ \\(by\\ skull\\ circumference\\)\ \(0\)\
\-\ premature\\ closure\\ of\\ the\\ anterior\\ and\\ posterior\\ fontanels\ \(0\)\
\-\ craniosynostosis\\ of\\ the\\ metopic\\ suture\ \(0\)\
\-\ skull\\ molding\ \(0\)\
\-\ craniosynostosis\ \(10\)\
\-\ 3\\.5\\ month\\-old\\ baby\\ girl\\ with\\ an\\ abnormally\\ shaped\\,\\ large\\ head\\,\\ and\\ prominent\\ scalp\\ veins\\.\ \(1\)\
\-\ craniosynostosis\\ is\\ the\\ early\\ fusion\\ of\\ one\\ or\\ more\\ of\\ the\\ cranial\\ sutures\\.\\ \\ in\\ this\\ case\\,\\ the\\ patient\\‚\\Ä\\ôs\\ metopic\\ suture\\ has\\ fused\\ early\\,\\ resulting\\ in\\ trigonocephaly\\.\ \(0\)\
\-\ the\\ incidence\\ of\\ craniosynostosis\\ in\\ newborns\\ is\\ approximately\\ \\.4\\ per\\ 1000\\ and\\ less\\ than\\ 10\\%\\ of\\ these\\ involve\\ the\\ metopic\\ suture\\.\ \(0\)\
\-\ metopic\\ craniosynostosis\\ usually\\ only\\ has\\ cosmetic\\ consequences\\,\\ and\\ the\\ patients\\ usually\\ have\\ normal\\ intellectual\\ development\\.\ \(0\)\
\-\ this\\ condition\\ is\\ usually\\ idiopathic\\,\\ but\\ there\\ are\\ other\\ varieties\\ of\\ craniosynostosis\\ that\\ are\\ components\\ of\\ syndromes\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ craniosynostosis\\:\\ 0\\.5955480585237446\ \(0\)\
\-\ metopic\\:\\ 0\\.3628158883871517\ \(0\)\
\-\ suture\\:\\ 0\\.29421173439744885\ \(0\)\
\-\ trigonocephaly\\:\\ 0\\.16075139376992018\ \(0\)\
\-\ hypotelorism\\:\\ 0\\.1513312472454231\ \(0\)\
\-\ the\\:\\ 0\\.1364354829490112\ \(0\)\
\-\ usually\\:\\ 0\\.1324474172739155\ \(0\)\
\-\ circumference\\:\\ 0\\.1195616706556925\ \(0\)\
\-\ early\\:\\ 0\\.1137410241462245\ \(0\)\
\-\ of\\:\\ 0\\.10293029335743609\ \(0\)\
\-\ are\\:\\ 0\\.09979113050681644\ \(0\)\
\-\ fusion\\:\\ 0\\.08836543626358527\ \(0\)\
\-\ skull\\:\\ 0\\.08535023171918045\ \(0\)\
\-\ exorbitism\\:\\ 0\\.08411429235790341\ \(0\)\
\-\ varieties\\:\\ 0\\.08411429235790341\ \(0\)\
\-\ 41cm\\:\\ 0\\.08037569688496009\ \(0\)\
\-\ fontanels\\:\\ 0\\.07772312118311137\ \(0\)\
\-\ molding\\:\\ 0\\.07772312118311137\ \(0\)\
\-\ necessitate\\:\\ 0\\.07398452571016804\ \(0\)\
\-\ consequences\\:\\ 0\\.07398452571016804\ \(0\)\
\-\ intellectual\\:\\ 0\\.07398452571016804\ \(0\)\
\-\ synthetic\\:\\ 0\\.07256317767743034\ \(0\)\
\-\ is\\:\\ 0\\.0720204335725476\ \(0\)\
\-\ fracturing\\:\\ 0\\.07133195000831934\ \(0\)\
\-\ newborns\\:\\ 0\\.07133195000831934\ \(0\)\
\-\ that\\:\\ 0\\.06847557112195993\ \(0\)\
\-\ operated\\:\\ 0\\.06839564389049659\ \(0\)\
\-\ corneal\\:\\ 0\\.06685531987205652\ \(0\)\
\-\ macrocephaly\\:\\ 0\\.0661720065026383\ \(0\)\
\-\ cosmetic\\:\\ 0\\.06553585697497617\ \(0\)\
\-\ in\\:\\ 0\\.06542231891089474\ \(0\)\
\-\ and\\:\\ 0\\.06521134190060249\ \(0\)\
\-\ sutures\\:\\ 0\\.06288328127312745\ \(0\)\
\-\ 1000\\:\\ 0\\.06288328127312745\ \(0\)\
\-\ head\\:\\ 0\\.06274018986164934\ \(0\)\
\-\ sixth\\:\\ 0\\.06082578371272763\ \(0\)\
\-\ helps\\:\\ 0\\.06046414869726447\ \(0\)\
\-\ together\\:\\ 0\\.059457275428948554\ \(0\)\
\-\ these\\:\\ 0\\.05940320391324126\ \(0\)\
\-\ patients\\:\\ 0\\.05917754617259263\ \(0\)\
\-\ parallel\\:\\ 0\\.05854960765873524\ \(0\)\
\-\ bone\\:\\ 0\\.057397288144014284\ \(0\)\
\-\ fused\\:\\ 0\\.05582527664565339\ \(0\)\
\-\ closure\\:\\ 0\\.05561330154091249\ \(0\)\
\-\ correct\\:\\ 0\\.05520343357696592\ \(0\)\
\-\ infants\\:\\ 0\\.054811012185791916\ \(0\)\
\-\ graft\\:\\ 0\\.054811012185791916\ \(0\)\
\-\ this\\:\\ 0\\.054219983215050054\ \(0\)\
\-\ syndromes\\:\\ 0\\.05407297752247243\ \(0\)\
\-\ scalp\\:\\ 0\\.053389664153054205\ \(0\)\
\-\ too\\:\\ 0\\.05290848484402329\ \(0\)\
\-\ case\\:\\ 0\\.05284847184697288\ \(0\)\
\-\ to\\:\\ 0\\.052596736155139816\ \(0\)\
\-\ abnormally\\:\\ 0\\.0523036443819596\ \(0\)\
\-\ newborn\\:\\ 0\\.05187470606796917\ \(0\)\
\-\ premature\\:\\ 0\\.05187470606796917\ \(0\)\
\-\ eyes\\:\\ 0\\.051072416712848595\ \(0\)\
\-\ primarily\\:\\ 0\\.05045335803523146\ \(0\)\
\-\ treatment\\:\\ 0\\.05010962632704349\ \(0\)\
\-\ exposure\\:\\ 0\\.04998639694175399\ \(0\)\
\-\ delay\\:\\ 0\\.048229720647373166\ \(0\)\
\-\ has\\:\\ 0\\.04804969060679357\ \(0\)\
\-\ earlier\\:\\ 0\\.04804344136314354\ \(0\)\
\-\ components\\:\\ 0\\.04777089410313027\ \(0\)\
\-\ metabolic\\:\\ 0\\.047681806347680385\ \(0\)\
\-\ close\\:\\ 0\\.04759357111971105\ \(0\)\
\-\ baby\\:\\ 0\\.04741959405339626\ \(0\)\
\-\ veins\\:\\ 0\\.04667493307936446\ \(0\)\
\-\ involve\\:\\ 0\\.046285824248297705\ \(0\)\
\-\ involves\\:\\ 0\\.04576726530915116\ \(0\)\
\-\ incidence\\:\\ 0\\.045276323679505445\ \(0\)\
\-\ symmetric\\:\\ 0\\.04507366692923055\ \(0\)\
\-\ factors\\:\\ 0\\.04449112517442984\ \(0\)\
\-\ idiopathic\\:\\ 0\\.04449112517442984\ \(0\)\
\-\ material\\:\\ 0\\.044304845890200215\ \(0\)\
\-\ shaped\\:\\ 0\\.043943210874737064\ \(0\)\
\-\ resulting\\:\\ 0\\.043767576784254025\ \(0\)\
\-\ their\\:\\ 0\\.043652318896492834\ \(0\)\
\-\ per\\:\\ 0\\.043652318896492834\ \(0\)\
\-\ development\\:\\ 0\\.04348208924374695\ \(0\)\
\-\ affected\\:\\ 0\\.043259897505318834\ \(0\)\
\-\ life\\:\\ 0\\.043150777758886746\ \(0\)\
\-\ cranial\\:\\ 0\\.042989481908928366\ \(0\)\
\-\ normal\\:\\ 0\\.04295012686102107\ \(0\)\
\-\ screening\\:\\ 0\\.04272677151827379\ \(0\)\
\-\ intracranial\\:\\ 0\\.042321409056962356\ \(0\)\
\-\ condition\\:\\ 0\\.04202866983620782\ \(0\)\
\-\ procedure\\:\\ 0\\.041933119644777216\ \(0\)\
\-\ increasing\\:\\ 0\\.04142459168334712\ \(0\)\
\-\ prominent\\:\\ 0\\.04142459168334712\ \(0\)\
\-\ placed\\:\\ 0\\.04098543673566947\ \(0\)\
\-\ pressure\\:\\ 0\\.04004833181360554\ \(0\)\
\-\ girl\\:\\ 0\\.03689620924494022\ \(0\)\
\-\ labs\\:\\ 0\\.03643978801653636\ \(0\)\
\-\ new\\:\\ 0\\.036387547021495874\ \(0\)\
\-\ less\\:\\ 0\\.03578270655943219\ \(0\)\
\-\ between\\:\\ 0\\.034175079242464844\ \(0\)\
\-\ approximately\\:\\ 0\\.03356081168522537\ \(0\)\
\-\ age\\:\\ 0\\.033021011111151376\ \(0\)\
\-\ only\\:\\ 0\\.032859715261192995\ \(0\)\
\-\ treated\\:\\ 0\\.03275373120972714\ \(0\)\
\-\ secondary\\:\\ 0\\.03117565683780071\ \(0\)\
\-\ 10\\:\\ 0\\.030756141632406968\ \(0\)\
\-\ months\\:\\ 0\\.03061579629032236\ \(0\)\
\-\ one\\:\\ 0\\.03011433708404668\ \(0\)\
\-\ mild\\:\\ 0\\.029815828604850044\ \(0\)\
\-\ than\\:\\ 0\\.029815828604850044\ \(0\)\
\-\ prior\\:\\ 0\\.029428197504350592\ \(0\)\
\-\ anterior\\:\\ 0\\.029367174707433347\ \(0\)\
\-\ more\\:\\ 0\\.028881460686999347\ \(0\)\
\-\ other\\:\\ 0\\.02731454413630427\ \(0\)\
\-\ posterior\\:\\ 0\\.027198439631063887\ \(0\)\
\-\ may\\:\\ 0\\.026468544086400952\ \(0\)\
\-\ large\\:\\ 0\\.026353782774910704\ \(0\)\
\-\ have\\:\\ 0\\.026275161172421395\ \(0\)\
\-\ but\\:\\ 0\\.026009372579347607\ \(0\)\
\-\ surgical\\:\\ 0\\.025563930338905756\ \(0\)\
\-\ by\\:\\ 0\\.02233580014210477\ \(0\)\
\-\ as\\:\\ 0\\.021130141615441123\ \(0\)\
\-\ there\\:\\ 0\\.020928242521149748\ \(0\)\
\-\ with\\:\\ 0\\.020598358836638044\ \(0\)\
\-\ an\\:\\ 0\\.020112973384249142\ \(0\)\
\-\ or\\:\\ 0\\.018297611718892697\ \(0\)\
\-\ patient\\:\\ 0\\.017107212270195838\ \(0\)\
\-\ on\\:\\ 0\\.015885241940931574\ \(0\)\
